A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate
Clinical trial NCT02184637 · COMPLETED
Trial details
- NCT number
- NCT02184637
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-31
- Primary completion
- 2015-04-08
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.